Skip to main content

Advertisement

SpringerLink
Log in

Choosing the appropriate left ventricular assist device for your patient

  • Review Article
  • Published:
Indian Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

The increasing incidence of advanced heart failure and severe donor organ shortage for cardiac transplant has led to the development of implantable left ventricular assist devices (LVAD) for long-term mechanical circulatory support. There has been tremendous improvement in the device technology of LVADs, and there are a number of devices in use throughout the world. This article reviews the evidence behind each device and their unique features that can help when choosing a durable LVAD for an individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–43.

    Article  CAS  Google Scholar 

  2. McCartney SL, Patel C, Del Rio JM. Long-term outcomes and management of the heart transplant recipient. Best Pract Res Clin Anaesthesiol. 2017;31:237–48.

    Article  Google Scholar 

  3. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137:e67–e492.

    Article  Google Scholar 

  4. Goldstein DJ, Oz MC, Rose EA. A. Implantable left ventricular assist devices. N Engl J Med. 1998;339:1522–33.

    Article  CAS  Google Scholar 

  5. Schumer EM, Black MC, Monreal G, Slaughter MS. Left ventricular assist devices: current controversies and future directions. Eur Heart J. 2016;37:3434–9.

    Article  Google Scholar 

  6. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.

    Article  CAS  Google Scholar 

  7. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312–21.

    Article  Google Scholar 

  8. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.

    Article  CAS  Google Scholar 

  9. Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370:33–40.

    Article  CAS  Google Scholar 

  10. Blitz A. Pump thrombosis-A riddle wrapped in a mystery inside an enigma. Ann Cardiothorac Surg. 2014;3:450–71.

    PubMed  PubMed Central  Google Scholar 

  11. Danter MR, McGee EC, Strueber M, et al. A prospective, controlled, un-blinded, multi-center clinical trial to evaluate the thoracotomy implant technique of the HVAD system in patients with advanced heart failure: results of the LATERAL Trial. J. Heart Lung Transplant. 2017;36:S66.

    Article  Google Scholar 

  12. Rich JD, Burkhoff D. HVAD flow waveform morphologies: theoretical foundation and implications for clinical practice. ASAIO J. 2017;63:526–35.

    Article  Google Scholar 

  13. Strueber M, O'Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol. 2011;57:1375–82.

    Article  Google Scholar 

  14. Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200.

    Article  Google Scholar 

  15. Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376:451–60.

    Article  Google Scholar 

  16. Milano CA, Rogers JG, Tatooles AJ, et al. HVAD: the ENDURANCE supplemental trial. JACC Heart Fail. 2018;0.6:792–802.

    Article  Google Scholar 

  17. Mehra MR, Naka Y, Uriel N, et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376:440–50.

    Article  Google Scholar 

  18. Netuka I, Sood P, Pya Y, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: A multicenter study. J Am Coll Cardiol. 2015;66:2579–89.

    Article  Google Scholar 

  19. Mehra MR, Goldstein DJ, Uriel N, et al. Two-Year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018;378:1386–95.

    Article  Google Scholar 

  20. Uriel N, Colombo PC, Cleveland JC, et al. Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure. Circulation. 2017;135:2003–12.

    Article  Google Scholar 

  21. Schmitto JD, Hanke JS, Dogan G, et al. First implantation of a Novel left ventricular assist device: the ReliantHeart aVAD. Ann Thorac Surg. 2017;104:e311–3.

    Article  Google Scholar 

  22. Pektok E, Demirozu ZT, Arat N, et al. Remote monitoring of left ventricular assist device parameters after HeartAssist-5 implantation. Artif Organs. 2013;37:820–5.

    PubMed  Google Scholar 

  23. Anyanwu AC, Fischer GW, Plotkina I, Pinney S, Adams DH. Off-pump implant of the Jarvik 2000 ventricular assist device through median sternotomy. Ann Thorac Surg. 2007;84:1405–7.

    Article  Google Scholar 

  24. Selzman CH, Sheridan BC. Off-pump insertion of continuous flow left ventricular assist devices. J Card Surg. 2007;22:320–2.

    Article  Google Scholar 

  25. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg. 2003;237:631–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Saito S, Yamazaki K, Nishinaka T, et al. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS. J. Heart Lung Transplant. 2014;33:599–608.

    Article  Google Scholar 

  27. Matsumoto Y, Fujita T, Fukushima S, et al. Comparison of hemodynamic performance and clinical results with EVAHEART versus HeartMate II. ASAIO J. 2017;63:562–7.

    Article  Google Scholar 

  28. Morshuis M, El-Banayosy A, Arusoglu L, et al. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg. 2009;35:1020–7.

    Article  Google Scholar 

  29. Schmid C, Tjan TD, Etz C, et al. First clinical experience with the Incor left ventricular assist device. J. Heart Lung Transplant. 2005;24:1188–94.

    Article  Google Scholar 

  30. Iacovoni A, Centofanti P, Attisani M, et al. Low incidence of gastrointestinal bleeding and pump thrombosis in patients receiving the INCOR LVAD system in the long-term follow-up. Int J Artif Organs. 2015;38:542–7.

    Article  Google Scholar 

Download references

Funding

No funding was required as this is a review article and not a publication of primary data.

Author information

Authors and Affiliations

  1. Department of Surgery Section of Cardiac Surgery, University of Chicago Medicine and Biological Sciences, Chicago, IL, 60637, USA

    Trever Symalla & Valluvan Jeevanandam

Authors
  1. Trever Symalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valluvan Jeevanandam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Trever Symalla.

Ethics declarations

Ethical

This article is a review of previously published work and of clinical experience and is not the publication of primary data. The article provides opinions based on this experience. The article complies with the ethical responsibilities outlined by the journal.

Human and animal rights

This article is a review article and not a publication of primary data.

Informed consent

This article is a review article and not a publication of primary data.

Conflicts of interest

Trever Symalla has no conflict(s) of interest. Valluvan Jeevanadam is a consultant for Abbott.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Symalla, T., Jeevanandam, V. Choosing the appropriate left ventricular assist device for your patient. Indian J Thorac Cardiovasc Surg 36 (Suppl 2), 256–264 (2020). https://doi.org/10.1007/s12055-019-00890-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12055-019-00890-3

Keywords

Search

Navigation